FAREHAM, United Kingdom—CooperVision reported Tuesday that it has acquired No7 Contact Lenses, which is based here. No7 Contact Lenses designs and manufactures specialty contact lenses that are distributed primarily in the United Kingdom. The company will operate within the CooperVision Specialty EyeCare group, complementing a portfolio of innovative products used by eyecare professionals to manage challenges such as myopia progression in children and irregular cornea, according to the announcement. Terms of the transaction between the formerly independent U.K. company and CooperVision were not disclosed.

“No7 Contact Lenses has been our partner for several years in the U.K. while expanding its business,” said Juan Carlos Aragón, OD, president of CooperVision Specialty EyeCare. “The acquisition will enable us to directly offer more of our products through No7’s well-established channels, while expanding access to their designs.”

He added, “In tandem, the agreement should further accelerate the development of myopia management solutions in the U.K.”

Ashley Pepper, managing director of No7 Contact Lenses, said the U.K. firm has great respect for CooperVision and has enjoyed a strong working relationship with its Specialty Eyecare team. Pepper added, “Today’s news will help us have an even greater impact on the eyecare professionals who prescribe our contact lenses, and the adults and children whose vision and lives are made better because of them.”

CooperVision Specialty EyeCare develops, manufacturers and provides worldwide access to a portfolio of industry leading soft custom and rigid gas permeable contact lens designs to address myopia management, irregular cornea management and presbyopia management. The group’s other brands include Blanchard, GP Specialists, Paragon, Procornea and Soflex.

No7 customers should continue to work with their current representatives and follow established ordering and support processes, the announcement noted.